Drug Delivery System
Online ISSN : 1881-2732
Print ISSN : 0913-5006
ISSN-L : 0913-5006
[Feature articles] “Progress in development of mRNA therapeutis and mRNA vaccines” Editor:Keiji Itaka
Translational regulation systems for “smart mRNA drugs” that enable controlled or targeted therapeutic effects
Hideyuki NakanishiKeiji Itaka
Author information
JOURNAL FREE ACCESS

2022 Volume 37 Issue 3 Pages 209-220

Details
Abstract
In the case of mRNA drugs, therapeutic effects are caused by proteins produced from mRNAs rather than mRNAs themselves. Thus, a system to regulate therapeutic protein production from mRNAs can function as a kind of drug delivery system. Regulation of protein production from mRNA drugs is more difficult than that from plasmid DNAs or viral vectors as mRNA drugs cannot utilize transcriptional regulatory sequences. However, various translational regulator systems have recently been developed. In this review, we introduce these translational regulator systems including our own studies.
Content from these authors
© 2022 The Japan Society of Drug Delivery System
Previous article Next article
feedback
Top